By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Robert W. Baird has upped its rating on Sigma-Aldrich's stock to "outperform" from "neutral," a day after the firm beat Wall Street expectations for fourth-quarter revenues and net income.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.